Zynerba Pharmaceuticals I... (ZYNE)
NASDAQ: ZYNE
· Real-Time Price · USD
1.30
0.03 (2.36%)
At close: Oct 10, 2023, 10:00 PM
Company Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company.
The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery.
The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014.
Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
Zynerba Pharmaceuticals Inc.
| Country | United States |
| IPO Date | Aug 5, 2015 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 25 |
| CEO | Armando Anido MBA |
Contact Details
Address: 80 West Lancaster Avenue Devon, Pennsylvania United States | |
| Website | https://www.zynerba.com |
Stock Details
| Ticker Symbol | ZYNE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001621443 |
| CUSIP Number | 98986X109 |
| ISIN Number | US98986X1090 |
| Employer ID | 26-0389433 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Armando Anido MBA | Chairman & Chief Executive Officer |
| Albert P. Parker II | Chief Legal Officer & Corporation Sec. |
| James E. Fickenscher | Chief Financial Officer & Vice President of Corporation Devel. (Leave of Absence) |
| Kenneth T. Jones | Vice President, Corporation Controller & Interim Chief Financial Officer |
| Joseph Apostolico | Vice President of HR |
| Terri B. Sebree | Pres |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 19, 2023 | 15-12G | Filing |
| Oct 11, 2023 | 4 | Filing |
| Oct 11, 2023 | 4 | Filing |
| Oct 11, 2023 | 4 | Filing |
| Oct 11, 2023 | 4 | Filing |
| Oct 11, 2023 | 4 | Filing |
| Oct 11, 2023 | 4 | Filing |
| Oct 11, 2023 | 4 | Filing |
| Oct 11, 2023 | 4 | Filing |